Home › Acute Myeloid Leukemia › California › San Jose
Acute Myeloid Leukemia clinical trials in San Jose, CA
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around San Jose (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Kaiser Permanente-Santa Teresa-San Jose, San Jose
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Dominican Santa Cruz Hospital, Santa Cruz · 26 mi away
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Kaiser Permanente-Santa Teresa-San Jose, San Jose
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX88 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Baldwin Park, CA41 studies
- Seattle, WA40 studies
- Durham, NC34 studies
- Columbus, OH34 studies
- Philadelphia, PA33 studies
- Atlanta, GA30 studies
- Tampa, FL30 studies
- Chicago, IL27 studies
- Los Angeles, CA25 studies
Other studies in San Jose
- Lung Cancer10 studies
- Major Depressive Disorder8 studies
- Breast Cancer7 studies
- Prostate Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Cancer (all types)6 studies
- Colon Cancer5 studies
- Ovarian Cancer4 studies
- Asthma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Melanoma4 studies
- Esophageal Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.